RSSS Director McPeak Now Holds 409K Shares After Major Option Exercise

Rhea-AI Filing Summary

Research Solutions (RSSS) director Merrill A. McPeak exercised stock options and acquired shares on June 18, 2025. Key transaction details:

• Exercised 75,000 stock options at a strike price of $1.10 per share
• Following the transaction, McPeak directly owns 409,608 shares
• The exercised options were set to expire on June 29, 2025
• The options were originally granted on June 30, 2015 with a 10-year term

This Form 4 filing represents a standard options exercise by an insider before expiration. The transaction timing appears to be driven by the approaching expiration date rather than any specific market outlook. The exercise increases McPeak's direct equity stake in the company, potentially indicating confidence in the company's long-term prospects.

Insider Trade Summary

75,000 shares exercised/converted

Mixed 2 txns

Insider MCPEAK MERRILL A

Role Director

Type	Security	Shares	Price	Value
Exercise	Option to purchase common stock	75,000	$0.00	--
Exercise	Common Stock	75,000	$1.10	$83K

Holdings After Transaction: Option to purchase common stock — 0 shares (Direct); Common Stock — 409,608 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCPEAK MERRILL A

(Last) (First) (Middle)

C/O RESEARCH SOLUTIONS, INC.

(Street)

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Research Solutions, Inc. [ RSSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2025		M		75,000	A	$1.1	409,608	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase common stock	$1.1	06/18/2025		M			75,000	06/30/2015	06/29/2025	Common Stock	75,000	$0	0	D

Explanation of Responses:

	/s/ William Nurthen, Attorney-in-Fact	06/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction occurred at RSSS on June 18, 2025?

Director Merrill A. McPeak exercised 75,000 stock options at a price of $1.10 per share, converting them to common stock. Following this transaction, McPeak owned 409,608 shares of RSSS common stock directly.

How many RSSS shares does Director McPeak own after the June 2025 transaction?

Following the stock option exercise on June 18, 2025, Director Merrill A. McPeak owned 409,608 shares of RSSS common stock directly.

What was the exercise price of RSSS stock options exercised by Director McPeak?

The stock options were exercised at a price of $1.10 per share. These options were set to expire on June 29, 2025, and had been exercisable since June 30, 2015.

Did RSSS Director McPeak sell any shares in this Form 4 filing?

No, Director McPeak did not sell any shares in this transaction. The Form 4 shows only the acquisition of shares through the exercise of stock options, converting 75,000 options into an equal number of common shares.